The Food and Drug Administration today authorized Innovative Health Solutions Inc. to market an electrical nerve stimulator device to relieve opioid withdrawal symptoms when placed behind the patient’s ear. Previously approved for use in acupuncture, the NSS-2 Bridge device reduced symptoms for patients undergoing opioid withdrawal during a clinical study by at least 31% within 30 minutes, based on the clinical opiate withdrawal scale. Sixty-four of the 73 patients in the study transitioned to medication assisted therapy after five days using the device. “The FDA is committed to supporting the development of novel treatments, both drugs and devices, that can be used to address opioid dependence or addiction, as well as new, non-addictive treatments for pain that can serve as alternatives to opioids,” said FDA Commissioner Scott Gottlieb, M.D.

Related News Articles

Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Blog
A recent article in Medical Care Journal paints a bleak picture of the future of healthcare, claiming hospitals intend to replace Registered Nurses (RNs)…
Chairperson's File
In this episode, I talk with Joy Parchment, R.N., assistant professor of nursing at the University of Central Florida. As a nurse leader, Joy has worked for…
Headline
The Coalition to Strengthen America’s Healthcare June 12 released a 30-second advertisement featuring real nurses discussing how hospitals and health systems…
Perspective
5801 Oxford Rd, Glen Echo, Md. 20812. If you ever find yourself in the Washington, D.C., area, that is the address of the Clara Barton National Historic Site,…
Perspective
In just a few days, we’ll kick off important recognitions for National Hospital Week, May 12-18, and National Nurses Week, May 6-12.Nurses, physicians,…